425 related articles for article (PubMed ID: 15838186)
21. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
Scharf MB; Sachais BA
J Clin Psychiatry; 1990 Sep; 51 Suppl():13-7. PubMed ID: 2211559
[TBL] [Abstract][Full Text] [Related]
22. First-night-effects on generalized anxiety disorder (GAD)-based insomnia: laboratory versus home sleep recordings.
Saletu B; Klösch G; Gruber G; Anderer P; Udomratn P; Frey R
Sleep; 1996 Nov; 19(9):691-7. PubMed ID: 9122554
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
24. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo.
Saletu A; Parapatics S; Anderer P; Matejka M; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):163-74. PubMed ID: 19603241
[TBL] [Abstract][Full Text] [Related]
25. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls.
Saletu B; Anderer P; Saletu M; Hauer C; Lindeck-Pozza L; Saletu-Zyhlarz G
Sleep Med; 2002 Nov; 3 Suppl():S35-42. PubMed ID: 14592166
[TBL] [Abstract][Full Text] [Related]
26. The effect of placebo administration on the first-night effect in healthy young volunteers.
Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
[TBL] [Abstract][Full Text] [Related]
27. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
28. Investigation of sleep disturbance in chronic low back pain: an age- and gender-matched case-control study over a 7-night period.
van de Water AT; Eadie J; Hurley DA
Man Ther; 2011 Dec; 16(6):550-6. PubMed ID: 21652257
[TBL] [Abstract][Full Text] [Related]
29. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
[TBL] [Abstract][Full Text] [Related]
30. The key-lock principle in the diagnosis and treatment of nonorganic insomnia related to psychiatric disorders: sleep laboratory investigations.
Saletu-Zyhlarz GM; Arnold O; Saletu B; Anderer P
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():37-49. PubMed ID: 12575467
[TBL] [Abstract][Full Text] [Related]
31. Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication.
Wichniak A; Wierzbicka A; Jernajczyk W
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1671-6. PubMed ID: 21723905
[TBL] [Abstract][Full Text] [Related]
32. Are there gender differences in objective and subjective sleep measures? A study of insomniacs and healthy controls.
Voderholzer U; Al-Shajlawi A; Weske G; Feige B; Riemann D
Depress Anxiety; 2003; 17(3):162-72. PubMed ID: 12768650
[TBL] [Abstract][Full Text] [Related]
33. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
[TBL] [Abstract][Full Text] [Related]
34. Sleep latency and duration estimates among sleep disorder patients: variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics.
Vanable PA; Aikens JE; Tadimeti L; Caruana-Montaldo B; Mendelson WB
Sleep; 2000 Feb; 23(1):71-9. PubMed ID: 10678467
[TBL] [Abstract][Full Text] [Related]
35. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
[TBL] [Abstract][Full Text] [Related]
37. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
39. [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use].
Wichniak A; Wierzbicka A; Sobańska A; Szatkowska E; Czasak K; Musińska I; Jernajczyk W
Pol Merkur Lekarski; 2007 Jul; 23(133):41-6. PubMed ID: 18051828
[TBL] [Abstract][Full Text] [Related]
40. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
